Saroja Pharma Industries India Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Saroja Pharma Industries India has a total shareholder equity of ₹146.4M and total debt of ₹57.4M, which brings its debt-to-equity ratio to 39.2%. Its total assets and total liabilities are ₹265.6M and ₹119.2M respectively. Saroja Pharma Industries India's EBIT is ₹26.0M making its interest coverage ratio 2.1. It has cash and short-term investments of ₹3.2M.
Belangrijke informatie
39.2%
Verhouding schuld/eigen vermogen
₹57.35m
Schuld
| Rente dekkingsratio | 2.1x |
| Contant | ₹3.22m |
| Aandelen | ₹146.42m |
| Totaal verplichtingen | ₹119.21m |
| Totaal activa | ₹265.62m |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: SAROJA's short term assets (₹176.0M) exceed its short term liabilities (₹92.9M).
Langlopende schulden: SAROJA's short term assets (₹176.0M) exceed its long term liabilities (₹26.3M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: SAROJA's net debt to equity ratio (37%) is considered satisfactory.
Schuld verminderen: Insufficient data to determine if SAROJA's debt to equity ratio has reduced over the past 5 years.
Schuldendekking: SAROJA's debt is not well covered by operating cash flow (17.9%).
Rentedekking: SAROJA's interest payments on its debt are not well covered by EBIT (2.1x coverage).